Accu-Chek Inform II Test Strip, Whole Blood Glucose Test System, Model number 05942891001

FDA Device Recall #Z-2354-2021 — Class II — July 28, 2021

Recall Summary

Recall Number Z-2354-2021
Classification Class II — Moderate risk
Date Initiated July 28, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diabetes Care, Inc.
Location Indianapolis, IN
Product Type Devices
Quantity 9,555,555 (US); 5,128,758 (OUS)

Product Description

Accu-Chek Inform II Test Strip, Whole Blood Glucose Test System, Model number 05942891001

Reason for Recall

Test strip vials may open while inside sealed cartons during shipment. An open vial might expose the test strips to humidity, which might damage the strips and result in inaccurate results, potentially leading to inappropriate therapy decisions and adverse health consequences.

Distribution Pattern

Worldwide distribution - US Nationwide distribution.

Lot / Code Information

Since this is a labeling correction, this recall is not lot specific and is applicable to all non-expired lots.

Other Recalls from Roche Diabetes Care, Inc.

Recall # Classification Product Date
Z-2174-2024 Class II Accu-Chek Guide (SC) Kit -Intended to quantitat... May 13, 2024
Z-1008-2022 Class II RocheDiabetes Care Platform Software version 2.... Mar 9, 2022
Z-2351-2021 Class II Accu-Chek Aviva Plus Test Strip, Blood Glucose ... Jul 28, 2021
Z-2353-2021 Class II Accu-Chek SmartView Test Strip, Blood Glucose M... Jul 28, 2021
Z-2352-2021 Class II Accu-Chek Performa Test Strip, Blood Glucose Mo... Jul 28, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.